Thyroid

Menu
Thyroid Physiology/Anatomy
  •  Anatomical considerations:
    •  Origination:
      • embryologically from pharyngeal epithelial evagination with additional contributions from lateral pharyngeal pouches
    •  Some properties of the fetal thyroid:
      • concentration and organification of iodine begins at 10 weeks gestation.
        • T4 and TSH (thyrotropin) are detectable (blood) shortly thereafter.
        • Increasing serum T4 due to:
          1. increased secretion
          2. appearance of thyroxine-binding globulin (TBG)
          3. increasing TSH concentration (following maturation of fetal hypothalamus which results in enhanced TRH (thyrotropic-releasing hormone) secretion.
    •  Adult thyroid: (anatomical aspects)
      •  Two lobes-- joined by an isthmus
      •  Found just anterior and caudal to the larynx cartilages
      •  Glands divided into pseudolobules by fibrous septa
      •  Pseudolobules: composed of follicles or acini (surrounded by capillaries)
      •  Follicles: composed of cuboidal epithelium
        • Luminal component -- proteinaceous colloid containing:
          1. thyroglobulin (peptide sequence -- T4 and T3 )
      • Thyroid also contains C cells:
        • source of calcitonin
        • malignant transformation of the cells result in medullary thyroid carcinoma
  • return to main menu

    return to main menu

    • Iodide:
      • Metabolism:
        • Iodide intake: gastrointestinal tract absorption from food, water, or medication.
        • Iodide:
          • rapid absorption
          • enters extracellular pool
          • thyroid removes amount required for hormone secretion
            • excess iodide: urinary excretion

    return to main menu

    • Thyroid hormone synthesis: Steps --
      • Iodide transport into the gland: iodide trapping
        • may be inhibited by thiocyanate, perchlorate, etc.
        • iodide removed from plasma by:
          • thyroid
          • kidneys
          • salivary and gastrointestinal glands (GI iodide reabsorbed)
        • Thyroid and kidney compete for plasma iodide:
          • Renal clearance --dependent on GFR (glomerular filtration rate), not affected by humoral factors or plasma iodide concentration
          • thyroid iodide uptake regulated by thyroid (not affected by renal factors)
        • Active Thyroid Transport involves:
          • Na+/I+ symporter
          • thyroid oxidative metabolism supplies energy cotransport
          • thyroid/plasma gradient equals 25: 1 to 500: 1

      return to main menu

      • Iodide then oxidized by thyroidal peroxidase (inhibited by thioamides) to iodine; (thyroidal peroxidase uses hydrogen peroxide generated by thyroid oxidative metabolism)
        • associated with iodination of newly synthesized thyroglobulin tyrosine residues forming:
          • monoiodotyrosine (MIT): iodide organification at cell-colloid interface
          • diiodotyrosine (DAT): iiodide organification at cell-colloid interface
        • Thyroglobulin: glycoprotein synthesized in thyroid follicular cells.
      • Two molecules of diiodotyrosine (DIT) combine within thyroglobulin to form L-thyroxine (T4). (oxidative condensation; peroxidase mediated)
      • One molecule of monoiodotyrosine (MIT) and one molecule of diiodotyrosine (DIT) combines to form T3. (oxidative condensation)
      • Thyroid hormone release:
        • exocytosis
        • proteolysis of thyroglobulin
          • Location: apical colloid border
        • Mechanism: Thyroglobulin (as colloid droplets{formed by pinocytosis of follicular colloid had apical cell margin}) in lysosomes is subject to action of proteolytic enzymes (inhibited by intrathyroidal iodide):
          • Thyroglobulin hydrolysis products:
            • T4 -- released
            • T3 -- released
            • MIT}deiodinated within the gland, iodine reutilized
            • DIT}deiodinated within the gland, iodine reutilized

      return to main menu

      • Thyroglobulin T4 /T3 ratio = 5:1 --therefore T4 (thyroxine) is primarily released; Circulating T3 levels mainly result from thyroxine peripheral metabolism.
      •  Above reactions may be inhibited by agents, collectively termed goitrogens which indirectly stimulate TSH secretion -- inducing goiter. Examples:
        • perchlorate -- inhibit iodide transport
        • thiocyanate -- inhibit iodide transport
        • thiourea derivatives: inhibit iodide oxidation; decrease DIT/MIT ratios; block coupling of iodotyrosines to active iodothyronines

    return to main menu

    • Hormonal transport:
      • T4 and T3 : protein bound -- primarily to thyroxine-binding globulin (TBG)
        • Others:
          1. T4 -- binding prealbumin
          2. albumin
          3. high-density lipoproteins
      • TBG (thyroxine-binding globulin): major determinant of normal binding
      • Changes in TBG concentration influence T4 and T3 levels:
        • increased TBG:serum T4 and T3 levels;percent FT4, FT3, RT3U
        • decreased TBG:serum T4 and T3 levels; percent FT4, FT3, RT3U
      • Two types of thyroid hormone-plasma protein anomalies:
        1. Thyroid-pituitary axis: normal with intact homeostatic thyroid hormone secretion control
          • Changes in TBG concentration is compensated for by mechanisms that insure return of free hormone concentration to normal
        2. Altered thyroid hormone buying interaction is due to primary change in thyroid hormone blood concentration, e.g. hypothyroidism or thyrotoxicosis-normal homeostatic control of hormone secretion is lost
          • TBG concentration changes little but free-hormone varies directly with total hormone concentration
          • homeostatic mechanisms do not function to restore hormone level and persistent abnormal levels result in altered metabolic state

    return to main menu

    • Thyroid Hormone Peripheral Metabolism:
      • Primary pathway for thyroxine peripheral metabolism:
        1. monodeiodination of T4 (outer ring)T3 (3,5,3'-triiodothyronine, 3 to 4 times more potent T4);
          • since about 30% of T4 is converted toT3 and given the relative potency of T3 and T4: nearly all of the metabolic effects of T4 is due to T3 derived from T4.
        2. deiodination of T4 (inner ring, 40%) reverse T3, RT3 (3,3',5'-triiodothyronine, metabolically inactive)
        3. 5'-deiodinase, required for T4 T3 conversion may be inhibited.
      • Second major pathway for T4 and T3 (and their metabolites) metabolism:
        • Hepatic metabolism:
          1. conjugation (glucuronate, sulfate)
          2. conjugates: either deiodinated locally or biliary excreted
          3. probably limited reabsorption
          4. Agents that increase metabolic clearance of thyroid hormone:
            • phenobarbital (Luminal)
            • phenytoin (Dilantin)-- total and free T4 reduced; normal metabolic state retained, possibly due to increasing T3 formation.
      • Causes of decreased T4 T3 conversion

    return to main menu

     Some Causes of Decreased T4 T3 conversion: Physiologic
    early neonatal life, fetal possibly old age

    return to main menu

     Some Causes of Decreased T4 T3 conversion: Pathologic
    fasting/malnutrition postoperative state systemic illness physical trauma

      return to main menu

     Some Causes of Decreased T4 T3 conversion: Pharmacological/other agents

    propylthiouracil

    dexamethasone (Decadron)

    propranolol (Inderal)

    amiodarone (Cordarone)

    ipodate (radiologic contrast agent)

    iopanoic acid (radiologic contrast agent)

    return to main menu

  • Greenspan, F.S., and Dong, B. J.. Histamine, Thyroid and Antithyroid Drugs, in Basic and Clinical Pharmacology, (Katzung, B. G., ed) Appleton-Lange, 1998, pp 619-633.
    Wartofsky, L., Diseases of the Thyroid, In Harrison's Principles of Internal Medicine 14th edition, (Isselbacher, K.J., Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S. and Kasper, D.L., eds) McGraw-Hill, Inc (Health Professions Division), 1998, pp 2012-2034